Cost of Revenue

$70.60M

TTM · Period ending: Mar 31, 2022 · USD

Latest reported$70.60Mperiod endingMar 31, 2022

ATRS TTM Cost of Revenue ($1.04M → $70.60M)

TTM cost of revenue

High-resolution chart · PNG

ATRS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Mar 31, 1997	1,236,272
Dec 31, 1996	1,036,272